Literature DB >> 34123547

To Reconstruct the Anterior Cruciate Ligament or Not? - Put into Panther Perspective.

Kristian Thorborg1.   

Abstract

Entities:  

Keywords:  anterior cruciate ligament; delayed; optional; reconstruction; return-to-sport

Year:  2021        PMID: 34123547      PMCID: PMC8168982          DOI: 10.26603/001c.24097

Source DB:  PubMed          Journal:  Int J Sports Phys Ther        ISSN: 2159-2896


× No keyword cloud information.
The anterior cruciate ligament, AKA the ACL, is the number one ligament of attention to the sports medicine professional. No other has received research and public attention like the ACL injury. Everyone knows and dreads it, from athlete to coach and young to old! Forty years ago, the ACL injury retired most pivoting sport athletes, and the big game-changer came in the late 80s when “the cure” arrived. The ligament was then primarily reconstructed with one’s own tendon tissue, and the instability problem solved long-term. The narrative around the ACL injury changed…it was no longer career ending. Problem solved – except not quite. I’ll never forget my first sports physical therapy conference in the United States. In a symposium debate on ACL injury, the conversation was entirely focused on graft choice – seemingly overlooking rehab as a first option. I was flabbergasted when the panel and floor together discussed and consented that the allograft was graft choice for the “couch potato,” due to it not being as strong/good as an autograft. But, did I hear this “consensus” right? When we know 50 percent of athletes who go through rehab first with optional delayed surgery, can proceed without surgery for the first 2-5 years! Unfortunately, I did! The idea of a specific graft type waiting for all who rupture their ACL is not driven by the scientific evidence. While ACL surgery is not cost-effective in the public healthcare system, it may be “cost-effective” in the private health care system – at least for those getting paid to do it. This may provide different perspectives and difficult conversations among healthcare professionals from different health care systems. Recently, the Panther consensus paper was released, including healthcare professionals from different countries and healthcare systems. The Panther consensus panel agreed 100% that both operative and non-operative care for ACL injury is acceptable – so far so good. However, whether rehab first with optional delayed surgery is an acceptable approach was not clearly addressed, although tackled in high-level randomized controlled trials. The Panther group disagreed on delayed operative care as an option for temporary return to athletic participation, following non-operative care and accepting the risk of additional injury. According to the experts, the elite athlete competing in pivoting sports needs a reconstruction - but despite lots of ACL research, we still only have Level 5 evidence from consensus. Even if we as experts promote shared decision-making, the expectations from younger athletes are already so high, and the procedure offered so quickly, that it seems questionable if athletes are ready and receptive for grasping mean outcomes and return to sport odds. Can we expect them to make truly informed and thoughtful decisions in a few weeks? So, how does it go with those who receive the procedure? Several graft choices later, the injury and its devastating consequence for many athletes still prevails. Many do not return to play at their pre-injury level, and of those who do, many have their sports career significantly shortened. At the same time, the rehab period these days is long – suggested to be up to two years – so many career dilemmas for the elite athlete exist. Future knee health may only play a small part in the decision on surgery and return to play times. The dream of ACL reconstruction as a career savior is understandable and a more attractive initial mind-set than the uncertainty around odds for successful recovery. But do we “sell” them a dream by suggesting immediate surgery? Why not delay the final decision and increase the athlete’s experience in life without an ACL? Why not see delayed optional surgery as a way to provide athletes with individual experiences on dynamic knee stability, strength and performance, as well as to form realistic expectations concerning different rehab strategies? It is suggested that the question “should you return to play?” needs posing. But is asking this question early in the process even feasible? In less than 50 milliseconds the life and identity of an athlete is turned upside down. With such an injury comes both shock and a grieving process! Athletes finding themselves again require time – not immediate surgery nor definite career decisions. ACL rehab is much more than graft choice, open versus closed kinetic chain exercises, and return to sport at pre-injury level. Psychological recovery and support may be important for athletes who want to return to sport - but what about those who can’t or won’t? They need just as much support. So, more focus and research on these perspectives, please, for the benefit of all athletes! The ligament “fixation” has stolen too much of our attention.
  10 in total

1.  Return to play guidelines after anterior cruciate ligament surgery.

Authors:  G Myklebust; R Bahr
Journal:  Br J Sports Med       Date:  2005-03       Impact factor: 13.800

Review 2.  Should Return to Sport be Delayed Until 2 Years After Anterior Cruciate Ligament Reconstruction? Biological and Functional Considerations.

Authors:  Christopher V Nagelli; Timothy E Hewett
Journal:  Sports Med       Date:  2017-02       Impact factor: 11.136

3.  Treatment after ACL injury: Panther Symposium ACL Treatment Consensus Group.

Authors:  Theresa Anita Diermeier; Ben B Rothrauff; Lars Engebretsen; Andrew Lynch; Eleonor Svantesson; Eric Andrew Hamrin Senorski; Sean J Meredith; Thomas Rauer; Olufemi R Ayeni; Mark Paterno; John W Xerogeanes; Freddie H Fu; Jon Karlsson; Volker Musahl
Journal:  Br J Sports Med       Date:  2020-07-13       Impact factor: 13.800

4.  Patient expectations of primary and revision anterior cruciate ligament reconstruction.

Authors:  Matthias J Feucht; Matthias Cotic; Tim Saier; Philipp Minzlaff; Johannes E Plath; Andreas B Imhoff; Stefan Hinterwimmer
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2014-10-02       Impact factor: 4.342

5.  Anterior Cruciate Ligament Reconstruction-Not Exactly a One-Way Ticket Back to the Preinjury Level: A Review of Contextual Factors Affecting Return to Sport After Surgery.

Authors:  Clare L Ardern
Journal:  Sports Health       Date:  2015-05       Impact factor: 3.843

Review 6.  Evidence-based recommendations for the management of anterior cruciate ligament (ACL) rupture.

Authors:  Stephanie R Filbay; Hege Grindem
Journal:  Best Pract Res Clin Rheumatol       Date:  2019-02-21       Impact factor: 4.098

7.  Early surgical reconstruction versus rehabilitation with elective delayed reconstruction for patients with anterior cruciate ligament rupture: COMPARE randomised controlled trial.

Authors:  Max Reijman; Vincent Eggerding; Eline van Es; Ewoud van Arkel; Igor van den Brand; Joost van Linge; Jacco Zijl; Erwin Waarsing; Sita Bierma-Zeinstra; Duncan Meuffels
Journal:  BMJ       Date:  2021-03-09

8.  Treatment for acute anterior cruciate ligament tear: five year outcome of randomised trial.

Authors:  Richard B Frobell; Harald P Roos; Ewa M Roos; Frank W Roemer; Jonas Ranstam; L Stefan Lohmander
Journal:  BMJ       Date:  2013-01-24

Review 9.  Psychological, social and contextual factors across recovery stages following a sport-related knee injury: a scoping review.

Authors:  Linda K Truong; Amber D Mosewich; Christopher J Holt; Christina Y Le; Maxi Miciak; Jackie L Whittaker
Journal:  Br J Sports Med       Date:  2020-02-14       Impact factor: 13.800

10.  ACL reconstruction for all is not cost-effective after acute ACL rupture.

Authors:  Vincent Eggerding; Max Reijman; Duncan Edward Meuffels; Eline van Es; Ewoud van Arkel; Igor van den Brand; Joost van Linge; Jacco Zijl; Sita Ma Bierma-Zeinstra; Marc Koopmanschap
Journal:  Br J Sports Med       Date:  2021-03-18       Impact factor: 13.800

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.